Hannah Levin asks about rumors concerning the sale (and imputed demise) of the sainted Comet, chez Slog. Commenters finger Caffe Vitta as the likely culprit.

On a side note, Slog, please adopt conventional article-and-comment linky pages such that your occasional flashes of wit may become more widely disseminated. Thank you.

NYT: A Cancer Drug Shows Promise, at a Price That Many Can’t Pay: “Genentech plans to charge about $100,000 a year for the drug Avastin as a treatment for breast and lung cancer.”

It certainly shows evidence of a well thought-out marketing program when you name your only-for-the-wealthy drug after a pre-boarding pirate cry.